Vertex to Present at the Credit Suisse Healthcare Conference on November 8
Get Alerts VRTX Hot Sheet
Join SI Premium – FREE
BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the Credit Suisse Healthcare Conference on Tuesday, November 8th at 3:30 p.m. ET
Management’s remarks will be available live through Vertex’s website at www.vrtx.com in the “Investors” section under the “Events and Presentations” page. A replay of the conference webcast will be archived on the company's website.
About Vertex
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For seven years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit www.vrtx.com.
(VRTX-WEB)
View source version on businesswire.com: http://www.businesswire.com/news/home/20161102006536/en/
Vertex Pharmaceuticals Incorporated
Investors:
Michael
Partridge, 617-341-6108
Eric Rojas, 617-961-7205
Zach Barber,
617-341-6470
Source: Vertex Pharmaceuticals Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
- Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process
- Steve Madden Announces First Quarter 2024 Earnings Release Date
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!